Pioneering dementia study
A Scottish medical research company is leading a worldwide sleep study which could radically reduce the symptoms associated with dementia.
Scotland is the first country to take part in the worldwide trial, and before the study is rolled out internationally, CPS Research is seeking to engage with 100 patients in Edinburgh to take part a nine-month study.
The groundbreaking trial is the first of its kind to investigate the use of sleep hormone melatonin as an add-on treatment for dementia. Melatonin is the natural hormone produced at night to prepare the body for sleep and produced throughout the night to maintain sleep.
Dr Gordon Crawford of CPS Research said: "With the help of volunteers from Edinburgh and worldwide we aim to establish that Melatonin helps combat sleeplessness in dementia patients."
Email to a friend
Print this page- Scottish independence: I don’t want ‘separatism’ says Sir Tom Farmer
- USA 5 - 1 Scotland: Donovan grabs hattrick as Scots routed in Florida
- Rangers administration: End game nears for fallen icon
- Rangers administration: Duff & Phelps ‘hopeful’ that Taxman will agree to CVA
- Rangers administration: Seeds of club’s destruction sown by Fergus McCann
Looking for...
Featured advertisers
Jobs
Search for a job
Motors
Search for a car
Property
Search for a house
Weather for Edinburgh
Monday 28 May 2012
Today
Sunny
Temperature: 9 C to 21 C
Wind Speed: 15 mph
Wind direction: North east
Tomorrow
Cloudy
Temperature: 10 C to 16 C
Wind Speed: 12 mph
Wind direction: North east
